Pfizer Announces European Union Approval Of A New Form Of Lipitor (atorvastatin) For Use In Children
Pfizer Inc. (NYSE: PFE) announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor...
Short URL: http://drugrehab.in/?p=46214
Posted by admin
on Jul 14 2010. Filed under Cholesterol, Medical News.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
